Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06438757
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2024-05-27
Brief Title:
Trial of JYB1904 in Patients With Allergic Asthma
Sponsor:
Jemincare
Organization:
Jemincare
Study Overview
Official Title:
Phase IIa Trial to Evaluate the PharmacokineticPharmacodynamic Characteristics and Safety of JYB1904 in Patients With Allergic Asthma
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This phase IIa trial is meant to evaluate the pharmacokinetics pharmacodynamics and safety of JYB1904 in patients with allergic asthma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None